marijuana stocks news

Aerogrow International, Inc. (AERO)

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 10,980   1,707   1,683   2,588  
Cost of Revenue 7,635 1,083 1,144 1,605
Gross Profit 3,345   624   539   983  
Operating Expenses
Research Development 82 116 82 (103)
Selling General and Administrative 2,348 989 1,093 1,322
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss 915   (481) (636) (236)
Income from Continuing Operations
Total Other Income/Expenses Net 371 11 (221) (1,915)
Earnings Before Interest And Taxes 1,286 (470) (857) (2,151)
Interest Expense 106 37 9
Income Before Tax 1,180 (507) (857) (2,160)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops 1,180 (507) (857) (2,160)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income 1,180   (507) (857) (2,160)
Preferred Stock And Other Adjustments (152) 154 (240) (1,089)
Net Income Applicable To Common Shares 1,028   (353) (1,097) (3,249)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

 1933 Industries Inc. (TGIF.CN) (TGIFF) Appoints Cannabis Entrepreneur Jeannette VanderMarel as Advisor

1933 Industries Appoints Cannabis Entrepreneur Jeannette VanderMarel as Advisor  1933 Industries Inc.…

IONIC BRANDS CORP. (IONC) (IONKF) Announces Its Zoots Premium Cannabis Infused Edibles Launch in Pharmacann’s Illinois Dispensaries

IONIC BRANDS Announces Its Zoots Premium Cannabis Infused Edibles Launch in Pharmacann’s…

The Green Organic Dutchman Holdings Ltd. (TGOD) (TGODF) Receives Cannabis Research Licence from Health Canada

The Green Organic Dutchman Receives Cannabis Research Licence from Health Canada  …

Cara Therapeutics, Inc. (CARA) to Webcast Presentation

Cara Therapeutics to Webcast Presentation at the Canaccord Genuity 37th Annual Growth…